Furthermore, miR-106b-5p promotes the progression of CC by targeting three key genes (GSK3B, VEGFA, PTK2) through three crucial pathways (PI3K-Akt signaling pathway, focal adhesion, and pathways in cancer). The gene discussed is AKT1; the disease is cancer.